Answers are grounded in this paper and cite their sources.
Purpose The aim of this prospective study was to compare the diagnostic performance of conventional breast ultrasound (US) assessment with S-Detect artificial intelligence (AI) for differentiating benign from malignant breast lesions. The study was not designed to assess reduction in biopsy rates. Materials and Methods A total of 130 women with 130 target breast lesions were prospectively evaluated from January 2024 to December 2025. One target lesion was analyzed per patient. Each lesion underwent conventional B-mode US with final BI-RADS assessment and S-Detect analysis. Final histopathology was used as the reference standard. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated with 95% confidence intervals (CIs), and paired classifications were compared using McNemar’s test. Results Histopathology showed 109 benign lesions (83.9%) and 21 malignant lesions (16.1%). Conventional US showed 90.5% sensitivity, 87.2% specificity, 57.6% PPV, 97.9% NPV, and 87.7% accuracy. S-Detect showed the same sensitivity (90.5%) but lower specificity (63.3%), PPV (32.2%), and accuracy (67.7%), with an NPV of 97.2%. S-Detect produced 40 false-positive results compared with 14 for conventional US. On paired comparison, S-Detect generated significantly more positive classifications (McNemar P < 0.001). Conclusion S-Detect showed sensitivity comparable to conventional US but lower specificity, PPV, and overall accuracy, with more false-positive results. Therefore, the current findings do not demonstrate a reduction in unnecessary biopsy. S-Detect may be used as an adjunct to conventional US assessment, but its clinical role requires further evaluation in larger prospective reader studies using predefined management rules.
No takes yet. Share an insight, caveat, or question.
Mahmoud et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: